novo nordisk wegovy - Search News

News

Novo Nordisk ends Wegovy sales on Hims & Hers

CBS News on MSN · 2d

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

The Motley Fool on MSN · 2d

Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know

Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ending of its deal with Hims & Hers jeopardizes the healthcare platform's goal to lead the weight loss market.

The Wall Street Journal on MSN · 2d

Hims & Hers Stock Drops More Than 30% After Novo Nordisk Breakup

The Danish maker of obesity drugs abruptly ended a Wegovy distribution deal with the telehealth firm, citing allegations about Hims’ compounding and deceptive marketing practices.

Novo Nordisk launches weight-loss drug Wegovy

Reuters on MSN · 1d

Novo Nordisk launches weight-loss drug Wegovy in India to compete with Lilly's Mounjaro

Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli Lilly began marketing its rival product Mounjaro in the world's most populous nation.

The Wall Street Journal on MSN · 3d

Novo Nordisk’s New Obesity Drug Beats Wegovy Weight Loss in Early Trial

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

Live Mint on MSN · 3h

Wegovy vs Mounjaro: Eli Lilly to launch full-dose pen device in India as obesity drug race heats up

With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, intensifying the race for India's booming obesity drug market.

18hon MSN

Why Shares in Novo Nordisk Lost Weight Today

Shares in Denmark's pharmaceutical giant Novo Nordisk ( NVO -4.99%) were lower by 4% as of 11 a.m. ET today. The move comes ...

1d

Long Island experts weigh in after Novo Nordisk ends deal with Hims & Hers over weight loss meds

Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...

2don MSN

Novo Nordisk launches weight-loss drug Wegovy in India to compete with rival Lilly's Mounjaro

By Rishika Sadam and Kashish Tandon HYDERABAD (Reuters) -Danish drugmaker Novo Nordisk launched its blockbuster weight-loss ...

Hims & Hers stock crashes over 20% on Wegovy shocker

Hims & Hers Health stock plunged after Novo Nordisk (NYSE: NVO) cut ties over concerns about its handling of Wegovy ...

24/7 Wall St.5d

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (June 2025)

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results